Sk Biopharmaceuticals Co Ltd (326030) — Tangible Net Worth Ratio
Sk Biopharmaceuticals Co Ltd (326030) has a Tangible Net Worth Ratio of 94.2% as of March 2026. This metric is calculated by deducting intangible assets (₩53.70 Billion) from net assets (₩932.05 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Sk Biopharmaceuticals Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Sk Biopharmaceuticals Co Ltd Tangible Net Worth Ratio (2016–2025)
This chart shows how Sk Biopharmaceuticals Co Ltd's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 94.2%, reflecting net assets of ₩932.05 Billion with intangible assets of ₩53.70 Billion KRW. For live market cap and overall valuation, see 326030 company net worth.
Annual Tangible Net Worth Ratio for Sk Biopharmaceuticals Co Ltd (2016–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Sk Biopharmaceuticals Co Ltd from 2016 to 2025, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Sk Biopharmaceuticals Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.0% | ₩826.27 Billion | ₩49.56 Billion | ₩1.20 Trillion | ▼ -0.6 pp |
| 2024 | 94.6% | ₩573.98 Billion | ₩30.84 Billion | ₩1.04 Trillion | ▲ +2.0 pp |
| 2023 | 92.6% | ₩320.95 Billion | ₩23.63 Billion | ₩723.17 Billion | ▼ -1.9 pp |
| 2022 | 94.6% | ₩316.56 Billion | ₩17.18 Billion | ₩664.24 Billion | ▼ -1.2 pp |
| 2021 | 95.7% | ₩444.19 Billion | ₩18.90 Billion | ₩643.65 Billion | ▲ +0.9 pp |
| 2020 | 94.8% | ₩379.07 Billion | ₩19.70 Billion | ₩500.24 Billion | ▼ -4.8 pp |
| 2018 | 99.6% | ₩58.63 Billion | ₩245.97 Million | ₩95.54 Billion | ▲ +0.1 pp |
| 2017 | 99.5% | ₩47.24 Billion | ₩245.97 Million | ₩98.37 Billion | ▼ -0.4 pp |
| 2016 | 99.9% | ₩147.69 Billion | ₩198.64 Million | ₩193.89 Billion | — |